Analyst consensus rating
Vor Biopharma Analyst Rating: Strong Buy
Direct answer
Vor Biopharma's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $39.00.
Forecast evidence checked October 19, 2026.
Get free Vor Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $18.03
- Average price target
- $39.00
- High price target
- $50.00
- Low price target
- $27.00
- Low target gap
- +49.8%
- Target upside
- +116.3%
- High target gap
- +177.3%
- Target range width
- 127.6%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Vor Biopharma?
Vor Biopharma has a verified Strong Buy consensus. The same dataset has an average price target of $39.00.
How far are Vor Biopharma's low and high targets from the recorded price?
The low target implies +49.8%, while the high target implies +177.3%.
How many analysts are included in Vor Biopharma's consensus?
The verified consensus includes 8 analysts.
How is Vor Biopharma's target upside or downside calculated?
The average target of $39.00 is divided by the recorded price of $18.03, then one is subtracted to produce +116.3%. This does not guarantee a future return.
When was Vor Biopharma's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.